Clinical trial
Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections
NCT02774382 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections
- Lead sponsor
- Hvidovre University Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 1, 2017
- Completion date
- January 31, 2019
- Enrollment
- 450 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
clostridium difficile